AGL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AGL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Agilon Health's enterprise value is $644 Mil. Agilon Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-222 Mil. Therefore, Agilon Health's EV-to-EBITDA for today is -2.90.
The historical rank and industry rank for Agilon Health's EV-to-EBITDA or its related term are showing as below:
During the past 6 years, the highest EV-to-EBITDA of Agilon Health was -1.07. The lowest was -369.39. And the median was -25.19.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2025-05-20), Agilon Health's stock price is $2.48. Agilon Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.590. Therefore, Agilon Health's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The historical data trend for Agilon Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
EV-to-EBITDA | Get a 7-Day Free Trial | - | -27.11 | -80.52 | -27.76 | -1.95 |
Agilon Health Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
EV-to-EBITDA | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-12.46 | -12.55 | -4.51 | -1.95 | -6.60 |
For the Medical Care Facilities subindustry, Agilon Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Agilon Health's EV-to-EBITDA falls into.
Agilon Health's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 643.582 | / | -221.729 | |
= | -2.90 |
Agilon Health's current Enterprise Value is $644 Mil.
Agilon Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-222 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health (NYSE:AGL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Agilon Health's PE Ratio (TTM) for today is calculated as:
PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 2.48 | / | -0.590 | |
= | At Loss |
Agilon Health's share price for today is $2.48.
Agilon Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.590.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Agilon Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Karen Mcloughlin | director | COGNIZANT TECHNOLOGY SOLUTIONS, 500 FRANK W. BURR BLVD., TEANECK NJ 07666 |
Silvana Battaglia | director | 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428 |
Diana Mckenzie | director | METLIFE, 200 PARK AVENUE, NEW YORK NY 10166 |
John William Wulf | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Steven Sell | director, officer: CEO & President | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Jeffrey A. Schwaneke | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Benjamin Shaker | officer: Chief Markets Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Timothy Gertsch | officer: Chief Accounting Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Cd&r Investment Associates Ix, Ltd. | 10 percent owner | MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194 |
Veeral Desai | officer: Chief Strategy & Dev. Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Benjamin Kornitzer | officer: Chief Med. & Quality Officer | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Priscilla Kasenchak | officer: Chief Accounting Officer | 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042 |
Michael L Smith | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Theodore Halkias | officer: Chief Business Officer | C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831 |
Joan Danieley | officer: Chief Administrative Officer | C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831 |
From GuruFocus
By GuruFocus News • 02-25-2025
By Business Wire • 02-21-2025
By GuruFocus News • 04-15-2025
By GuruFocus News • 02-23-2025
By Business Wire • 02-25-2025
By GuruFocus News • 03-25-2025
By GuruFocus News • 04-17-2025
By GuruFocus News • 04-08-2025
By GuruFocus News • 04-08-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.